Adverse Events, Comorbidities, and HIVTuberculosis

Two New Classes of TB Drugs -- the First in 40 Years -- Advance Through Phase II Studies

After 40 Years of Scientific Stagnation, It Is Beginning to Be an Exciting Time in Tuberculosis Treatment Research

    Since the heyday of TB drug development in the 1950s and '60s, no new class of TB drugs has been approved to treat the disease. However, over the past few years TB drug development has experienced a minor renaissance.

    Claire Wingfield

    Treatment Action Group

    Treatment Action Group